Cytomed director, 10% owner Choo Chee Kong acquires $300,000 in common shares
GDTC•Director and 10% owner reports share transactions
- Cytomed Therapeutics: Director and 10% owner Choo Chee Kong disclosed sales of 200,000 ordinary shares at USD 1.5 each.
- Direct holding in ordinary shares increased to 630,324 shares following the reported transactions.
